Trandolapril and Haematocrit decreased - a phase IV clinical study of FDA data

Summary:

Haematocrit decreased is reported as a side effect among people who take Trandolapril (trandolapril), especially for people who are female, 30-39 old, also take Gravol, and have Relapsing-remitting multiple sclerosis.

The phase IV clinical study analyzes which people have Haematocrit decreased when taking Trandolapril. It is created by eHealthMe based on reports of 2,634 people who have side effects when taking Trandolapril from the FDA, and is updated regularly.

What is Trandolapril?

Trandolapril has active ingredients of trandolapril. It is often used in high blood pressure. eHealthMe is studying from 2,682 Trandolapril users. Check the latest studies of Trandolapril.

What is Haematocrit decreased?

Haematocrit decreased is found to be associated with 1,630 drugs and 2,399 conditions by eHealthMe. Check the latest studies of Haematocrit decreased.

On Jul, 30, 2026

2,634 people reported to have side effects when taking Trandolapril.
Among them, 31 people (1.18%) have Haematocrit decreased.

Could Trandolapril cause Haematocrit decreased?

Among these 31 people:

What is the gender of people who have Haematocrit decreased when taking Trandolapril? *

female: 80.65 %
male: 19.35 %

What is the age of people who have Haematocrit decreased when taking Trandolapril? *

What are other drugs people take besides Trandolapril? *

Amlodipine: 18 people, 58.06%
Pantoprazole: 18 people, 58.06%
Gravol: 18 people, 58.06%
Tylenol: 13 people, 41.94%
Benadryl: 7 people, 22.58%
Acetaminophen: 3 people, 9.68%
Aldactone: 3 people, 9.68%
Paracetamol: 3 people, 9.68%
Flunisolide: 2 people, 6.45%
Loperamide Hydrochloride: 2 people, 6.45%

What are other side effects people have besides Haematocrit decreased? *

White Blood Cell Count Decreased: 20 people, 64.52%
Hypotension (abnormally low blood pressure): 20 people, 64.52%
Abdominal Pain: 19 people, 61.29%
Nausea (feeling of having an urge to vomit): 19 people, 61.29%
Skin Blushing/flushing (a sudden reddening of the face, neck): 18 people, 58.06%
Abscess (pus): 18 people, 58.06%
Arrhythmias (irregular heartbeat): 18 people, 58.06%
Dizziness: 18 people, 58.06%
Drowsiness: 18 people, 58.06%
Fatigue (feeling of tiredness): 18 people, 58.06%

What are the existing conditions these people have? *

Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 17 people, 54.84%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 2 people, 6.45%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 6.45%
Hypokalemia (low potassium): 2 people, 6.45%
Gastrointestinal Pain: 2 people, 6.45%
Back Pain: 2 people, 6.45%
Pain: 1 person, 3.23%
Idiopathic Pulmonary Fibrosis (chronic lung disease): 1 person, 3.23%
Breast Cancer Metastatic: 1 person, 3.23%

* Approximation only. Some reports may have incomplete information.

Do you take Trandolapril and have Haematocrit decreased?

- Check whether Haematocrit decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Trandolapril:

Trandolapril (2,682 reports)

Browse all side effects of Trandolapril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Haematocrit decreased:

Haematocrit decreased (1,630 drugs)

Browse all the conditions that are associated with Haematocrit decreased:

Haematocrit decreased (2,399 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on trandolapril (the active ingredients of Trandolapril) and Trandolapril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.